{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T10:54:20Z","timestamp":1753181660513},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00105-023-05132-7","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T10:02:43Z","timestamp":1679997763000},"page":"340-349","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Psoriasis im Kindes- und Jugendalter","Psoriasis in children and adolescents"],"prefix":"10.1007","volume":"74","author":[{"given":"Henning","family":"Hamm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter H.","family":"H\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"5132_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000381913","volume":"231","author":"M Augustin","year":"2015","unstructured":"Augustin\u00a0M, Radtke\u00a0MA, Glaeske\u00a0G et\u00a0al (2015) Epidemiology and comorbidity in children with psoriasis and atopic eczema. Dermatology 231:35\u201340","journal-title":"Dermatology"},{"key":"5132_CR2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2340\/00015555-3036","volume":"99","author":"IMGJ Bronckers","year":"2019","unstructured":"Bronckers\u00a0IMGJ, Bruins\u00a0FM, van Geel\u00a0MJ et al (2019) Nail involvement as a\u00a0predictor of disease severity in paediatric psoriasis: follow-up data from the Dutch childCAPTURE registry. Acta Derm Venereol 99:152\u2013157","journal-title":"Acta Derm Venereol"},{"key":"5132_CR3","doi-asserted-by":"publisher","first-page":"adv00745","DOI":"10.2340\/actadv.v102.1000","volume":"102","author":"FM Bruins","year":"2022","unstructured":"Bruins\u00a0FM, Van Acht\u00a0MR, Bronckers\u00a0IMGJ et al (2022) Real-world methotrexate use in a\u00a0prospective cohort of paediatric patients with plaque psoriasis: effectiveness, adverse events and folic acid regimen. Acta Derm Venereol 102:adv745","journal-title":"Acta Derm Venereol"},{"key":"5132_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/bjd.20689","volume":"186","author":"E Burden-Teh","year":"2022","unstructured":"Burden-Teh\u00a0E, Murphy\u00a0R, Gran\u00a0S et al (2022) Identifying the best predictive diagnostic criteria for psoriasis in children (<\u202f18\u00a0years): a\u00a0UK multicentre case-control diagnostic accuracy study (DIPSOC study). Br J Dermatol 186:341\u2013351","journal-title":"Br J Dermatol"},{"key":"5132_CR5","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/pde.14712","volume":"38","author":"BM Cyrenne","year":"2021","unstructured":"Cyrenne\u00a0BM, Parpia\u00a0AS, Sibbald\u00a0C (2021) Paradoxical psoriasis in pediatric patients: a systematic review. Pediatr Dermatol 38:1086\u20131093","journal-title":"Pediatr Dermatol"},{"key":"5132_CR6","doi-asserted-by":"publisher","first-page":"11128","DOI":"10.3390\/ijms231911128","volume":"23","author":"F Diotallevi","year":"2022","unstructured":"Diotallevi\u00a0F, Simonetti\u00a0O, Rizzetto\u00a0G et\u00a0al (2022) Biological treatments for pediatric psoriasis: state of the art and future perspectives. Int J Mol Sci 23:11128","journal-title":"Int J Mol Sci"},{"key":"5132_CR7","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/pde.14779","volume":"38","author":"CP Frare","year":"2021","unstructured":"Frare\u00a0CP, Blumstein\u00a0AJ, Paller\u00a0AS et al (2021) CARD14-associated papulosquamous eruption (CAPE) in pediatric patients: three additional cases and review of the literature. Pediatr Dermatol 38:1237\u20131242","journal-title":"Pediatr Dermatol"},{"key":"5132_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/bjd.19747","volume":"185","author":"H Hamm","year":"2021","unstructured":"Hamm\u00a0H, Wilsmann-Theis\u00a0D, Tsianakas\u00a0A et al (2021) Efficacy and safety of fumaric acid esters in young patients aged 10\u201317\u00a0years with moderate-to-severe plaque psoriasis: a\u00a0randomized, double-blinded, placebo-controlled trial. Br J Dermatol 185:62\u201373","journal-title":"Br J Dermatol"},{"key":"5132_CR9","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/children8111057","volume":"8","author":"KA Kelly","year":"2021","unstructured":"Kelly\u00a0KA, Balogh\u00a0EA, Kaplan\u00a0SG, Feldman\u00a0SR (2021) Skin disease in children: effects on quality of life, stigmatization, bullying, and suicide risk in pediatric acne, atopic dermatitis, and psoriasis patients. Children 8:1057","journal-title":"Children"},{"key":"5132_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/ajd.13471","volume":"62","author":"E Kim","year":"2021","unstructured":"Kim\u00a0E, Lee\u00a0G, Fischer\u00a0G (2021) Use of narrowband ultraviolet B (NBUVB) in paediatric psoriasis: a systematic literature review and meta-analysis. Australas J Dermatol 62:124\u2013129","journal-title":"Australas J Dermatol"},{"key":"5132_CR11","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1111\/jdv.15213","volume":"33","author":"TA Kouwenhoven","year":"2019","unstructured":"Kouwenhoven\u00a0TA, Bronckers\u00a0IMGJ, van de Kerkhof\u00a0PCM et\u00a0al (2019) Psoriasis dermatitis: an overlap condition of psoriasis and atopic dermatitis in children. J\u00a0Eur Acad Dermatol Venereol 33:e74\u2013e76","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5132_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40272-022-00507-0","volume":"24","author":"N Magnolo","year":"2022","unstructured":"Magnolo\u00a0N, Kingo\u00a0K, Laquer\u00a0V et\u00a0al (2022) Efficacy of secukinumab across subgroups and overall safety in pediatric patients with moderate to severe plaque psoriasis: week 52 results from a\u00a0phase iii randomized study. Paediatr Drugs 24:377\u2013387","journal-title":"Paediatr Drugs"},{"key":"5132_CR13","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3390\/healthcare10071190","volume":"10","author":"A Marani","year":"2022","unstructured":"Marani\u00a0A, Rizzetto\u00a0G, Radi\u00a0G et\u00a0al (2022) Metabolic comorbidities and cardiovascular disease in pediatric psoriasis: a\u00a0narrative review. Healthcare 10:1190","journal-title":"Healthcare"},{"key":"5132_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.22551\/2022.37.0904.10227","volume":"9","author":"AM Morosanu","year":"2022","unstructured":"Morosanu\u00a0AM, Mihai\u00a0IR, Rezus\u00a0II et\u00a0al (2022) New onset severe ulcerative colitis following ixekizumab therapy. Arch Clin Cases 9:173\u2013176","journal-title":"Arch Clin Cases"},{"key":"5132_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/pde.13772","volume":"36","author":"AS Paller","year":"2019","unstructured":"Paller\u00a0AS, Schenfeld\u00a0J, Accortt\u00a0NA, Kricorian\u00a0G (2019) A retrospective cohort study to evaluate the development of comorbidities, including psychiatric comorbidities, among a\u00a0pediatric psoriasis population. Pediatr Dermatol 36:290\u2013297","journal-title":"Pediatr Dermatol"},{"key":"5132_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1001\/jamadermatol.2022.0655","volume":"158","author":"AS Paller","year":"2022","unstructured":"Paller\u00a0AS, Seyger\u00a0MMB, Magari\u00f1os\u00a0GA et al (2022) Long-term efficacy and safety of up to 108\u00a0weeks of ixekizumab in pediatric patients with moderate to severe plaque psoriasis: the IXORA-PEDS randomized clinical trial. JAMA Dermatol 158:533\u2013541","journal-title":"JAMA Dermatol"},{"key":"5132_CR17","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/pde.14820","volume":"38","author":"JJ Parker","year":"2021","unstructured":"Parker\u00a0JJ, Sugarman\u00a0JL, Silverberg\u00a0NB et al (2021) Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children. Pediatr Dermatol 38:1500\u20131505","journal-title":"Pediatr Dermatol"},{"key":"5132_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/pde.14208","volume":"37","author":"K Phan","year":"2020","unstructured":"Phan\u00a0K, Lee\u00a0G, Fischer\u00a0G (2020) Pediatric psoriasis and association with cardiovascular and metabolic comorbidities: systematic review and meta-analysis. Pediatr Dermatol 37:661\u2013669","journal-title":"Pediatr Dermatol"},{"key":"5132_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/pde.13028","volume":"34","author":"D Pourchot","year":"2017","unstructured":"Pourchot\u00a0D, Bodemer\u00a0C, Phan\u00a0A et\u00a0al (2017) Nail psoriasis: a\u00a0systematic evaluation in 313\u00a0children with psoriasis. Pediatr Dermatol 34:58\u201363","journal-title":"Pediatr Dermatol"},{"key":"5132_CR20","unstructured":"S2k-Leitlinie (2021) \u201eTherapie der Psoriasis bei Kindern und Jugendlichen\u201c (AWMF-Register-Nr.\u00a0013-094)"},{"key":"5132_CR21","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jaad.2021.10.028","volume":"87","author":"M Sachdeva","year":"2022","unstructured":"Sachdeva\u00a0M, Rankin\u00a0BD, Mufti\u00a0A et al (2022) Management of pediatric generalized pustular psoriasis using biologics: an evidence-based review. J\u00a0Am Acad Dermatol 87:484\u2013486","journal-title":"J Am Acad Dermatol"},{"key":"5132_CR22","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.jaad.2020.02.065","volume":"82","author":"MC Schneeweiss","year":"2020","unstructured":"Schneeweiss\u00a0MC, Huang\u00a0JT, Wyss\u00a0R et al (2020) Serious infection risk in children with psoriasis on systemic treatment: a propensity score-matched population-based study. J\u00a0Am Acad Dermatol 82:1337\u20131345","journal-title":"J Am Acad Dermatol"},{"key":"5132_CR23","doi-asserted-by":"publisher","first-page":"adv00660","DOI":"10.2340\/actadv.v101.981","volume":"102","author":"MMB Seyger","year":"2022","unstructured":"Seyger\u00a0MMB, Augustin\u00a0M, Sticherling\u00a0M et al (2022) Physician-reported clinical unmet needs, burden and treatment patterns of paediatric psoriasis patients: a US and EU real-world evidence study. Acta Derm Venereol 102:adv660","journal-title":"Acta Derm Venereol"},{"key":"5132_CR24","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jaad.2021.02.057","volume":"85","author":"NH Shear","year":"2021","unstructured":"Shear\u00a0NH, Betts\u00a0KA, Soliman\u00a0AM et al (2021) Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: a network meta-analysis of clinical trial data. J\u00a0Am Acad Dermatol 85:572\u2013581","journal-title":"J Am Acad Dermatol"},{"key":"5132_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jid.2020.02.048","volume":"141","author":"CH Smith","year":"2021","unstructured":"Smith\u00a0CH, Mahil\u00a0SK, Yiu\u00a0ZZN et al (2021) Quantitative evaluation of biologic therapy options for psoriasis: a systematic review and network meta-analysis-correction. J\u00a0Invest Dermatol 141:177\u2013181","journal-title":"J Invest Dermatol"},{"key":"5132_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/pde.14870","volume":"39","author":"HY Sun","year":"2022","unstructured":"Sun\u00a0HY, Phan\u00a0K, Paller\u00a0AS, Sebaratnam\u00a0DF (2022) Biologics for pediatric psoriasis: a systematic review and meta-analysis. Pediatr Dermatol 39:42\u201348","journal-title":"Pediatr Dermatol"},{"key":"5132_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s40257-021-00603-w","volume":"22","author":"A Thatiparthi","year":"2021","unstructured":"Thatiparthi\u00a0A, Martin\u00a0A, Liu\u00a0JK et al (2021) Biologic treatment algorithms for moderate-to-severe psoriasis with comorbid conditions and special populations: a review. Am J Clin Dermatol 22:425\u2013442","journal-title":"Am J Clin Dermatol"},{"key":"5132_CR28","doi-asserted-by":"publisher","first-page":"e12817","DOI":"10.1111\/dth.12817","volume":"32","author":"E Thomaidou","year":"2019","unstructured":"Thomaidou\u00a0E, Ramot\u00a0Y (2019) Injection site reactions with the use of biological agents. Dermatol Ther 32:e12817","journal-title":"Dermatol Ther"},{"key":"5132_CR29","doi-asserted-by":"publisher","first-page":"e15777","DOI":"10.1111\/dth.15777","volume":"35","author":"J Yeung","year":"2022","unstructured":"Yeung\u00a0J, Bourcier\u00a0M, Gooderham\u00a0MJ et al (2022) Management of moderate-to-severe plaque psoriasis with biologics: a treat-to-target position paper. Dermatol Ther 35:e15777","journal-title":"Dermatol Ther"},{"key":"5132_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3892\/ijmm.2021.4951","volume":"47","author":"J Zhou","year":"2021","unstructured":"Zhou\u00a0J, Luo\u00a0Q, Cheng\u00a0Y et\u00a0al (2021) An update on genetic basis of generalized pustular psoriasis (review). Int J Mol Med 47:118","journal-title":"Int J Mol Med"},{"key":"5132_CR31","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1111\/jdv.18361","volume":"36","author":"J Zitouni","year":"2022","unstructured":"Zitouni\u00a0J, Bursztejn\u00a0AC, Belloni Fortina\u00a0A et al (2022) Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry). J\u00a0Eur Acad Dermatol Venereol 36:2076\u20132086","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5132_CR32","doi-asserted-by":"publisher","first-page":"adv00244","DOI":"10.2340\/00015555-3602","volume":"100","author":"M \u017bychowska","year":"2020","unstructured":"\u017bychowska\u00a0M, Reich\u00a0A, Maj\u00a0J et\u00a0al (2020) Impact of childhood psoriasis on caregivers\u2019 quality of life, measured with family dermatology life quality index. Acta Derm Venereol 100:adv244","journal-title":"Acta Derm Venereol"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05132-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-023-05132-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05132-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T01:23:35Z","timestamp":1683768215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-023-05132-7"}},"subtitle":["Kurzes Update und leitliniengerechte Therapie","Short update and guideline-based treatment"],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["5132"],"URL":"https:\/\/doi.org\/10.1007\/s00105-023-05132-7","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"14 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.\u00a0Hamm hat Honorare f\u00fcr Beratert\u00e4tigkeiten, Vortr\u00e4ge und die Durchf\u00fchrung von Studien von folgenden Pharmaunternehmen erhalten: Allergika Pharma GmbH, 82515 Wolfratshausen, Biogen GmbH, 85737 Ismaning, InfectoPharm Arzneimittel und Consilium GmbH, 64646 Heppenheim, Lilly Deutschland GmbH, Werner-Reimers-Stra\u00dfe 2\u20134, 61352 Bad Homburg v.\u00a0d.\u00a0H., Novartis Pharma AG, CH-4002 Basel, Novartis Pharma AG Deutschland, 90429 N\u00fcrnberg, Pierre Fabre Dermo Kosmetik GmbH, 79111 Freiburg. P.H.\u00a0H\u00f6ger hat Honorare f\u00fcr Beratert\u00e4tigkeiten, Vortr\u00e4ge und die Durchf\u00fchrung von Studien von folgenden Pharmaunternehmen erhalten: 1.\u00a0Unterst\u00fctzung klinischer Forschung: AbbVie Deutschland GmbH Co. KG, 67061 Ludwigshafen, Lilly Deutschland GmbH, 61352 Bad Homburg v.\u00a0d.\u00a0H., Mayne Pharma US, Raleigh, NC 27609, Novartis Pharma AG Deutschland, 90429 N\u00fcrnberg 2.\u00a0Beratung: AbbVie Deutschland GmbH Co. KG, 67061 Ludwigshafen, Novartis Pharma AG Deutschland, 90429 N\u00fcrnberg, Klinge Pharma GmbH, 83607 Holzkirchen, Golin, 22761 Hamburg 3.\u00a0Vortragshonorare: Thieme Verlag KG, 70469 Stuttgart, Novartis Pharma AG Deutschland, 90429 N\u00fcrnberg, Beiersdorf AG, 20245 Hamburg.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}